AGO really Looks like it's consolidation is over. Some expansion arriving soon. There's a projection target of 5.3c which , interestingly also co-insides with the Feb high. Great volume build up. GL.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%